Cargando…

Extending the susceptible‐exposed‐infected‐removed (SEIR) model to handle the false negative rate and symptom‐based administration of COVID‐19 diagnostic tests: SEIR‐fansy

False negative rates of severe acute respiratory coronavirus 2 diagnostic tests, together with selection bias due to prioritized testing can result in inaccurate modeling of COVID‐19 transmission dynamics based on reported “case” counts. We propose an extension of the widely used Susceptible‐Exposed...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhaduri, Ritwik, Kundu, Ritoban, Purkayastha, Soumik, Kleinsasser, Michael, Beesley, Lauren J., Mukherjee, Bhramar, Datta, Jyotishka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035093/
https://www.ncbi.nlm.nih.gov/pubmed/35224743
http://dx.doi.org/10.1002/sim.9357
_version_ 1784693230549336064
author Bhaduri, Ritwik
Kundu, Ritoban
Purkayastha, Soumik
Kleinsasser, Michael
Beesley, Lauren J.
Mukherjee, Bhramar
Datta, Jyotishka
author_facet Bhaduri, Ritwik
Kundu, Ritoban
Purkayastha, Soumik
Kleinsasser, Michael
Beesley, Lauren J.
Mukherjee, Bhramar
Datta, Jyotishka
author_sort Bhaduri, Ritwik
collection PubMed
description False negative rates of severe acute respiratory coronavirus 2 diagnostic tests, together with selection bias due to prioritized testing can result in inaccurate modeling of COVID‐19 transmission dynamics based on reported “case” counts. We propose an extension of the widely used Susceptible‐Exposed‐Infected‐Removed (SEIR) model that accounts for misclassification error and selection bias, and derive an analytic expression for the basic reproduction number [Formula: see text] as a function of false negative rates of the diagnostic tests and selection probabilities for getting tested. Analyzing data from the first two waves of the pandemic in India, we show that correcting for misclassification and selection leads to more accurate prediction in a test sample. We provide estimates of undetected infections and deaths between April 1, 2020 and August 31, 2021. At the end of the first wave in India, the estimated under‐reporting factor for cases was at 11.1 (95% CI: 10.7,11.5) and for deaths at 3.58 (95% CI: 3.5,3.66) as of February 1, 2021, while they change to 19.2 (95% CI: 17.9, 19.9) and 4.55 (95% CI: 4.32, 4.68) as of July 1, 2021. Equivalently, 9.0% (95% CI: 8.7%, 9.3%) and 5.2% (95% CI: 5.0%, 5.6%) of total estimated infections were reported on these two dates, while 27.9% (95% CI: 27.3%, 28.6%) and 22% (95% CI: 21.4%, 23.1%) of estimated total deaths were reported. Extensive simulation studies demonstrate the effect of misclassification and selection on estimation of [Formula: see text] and prediction of future infections. A R‐package SEIRfansy is developed for broader dissemination.
format Online
Article
Text
id pubmed-9035093
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90350932022-05-17 Extending the susceptible‐exposed‐infected‐removed (SEIR) model to handle the false negative rate and symptom‐based administration of COVID‐19 diagnostic tests: SEIR‐fansy Bhaduri, Ritwik Kundu, Ritoban Purkayastha, Soumik Kleinsasser, Michael Beesley, Lauren J. Mukherjee, Bhramar Datta, Jyotishka Stat Med Research Articles False negative rates of severe acute respiratory coronavirus 2 diagnostic tests, together with selection bias due to prioritized testing can result in inaccurate modeling of COVID‐19 transmission dynamics based on reported “case” counts. We propose an extension of the widely used Susceptible‐Exposed‐Infected‐Removed (SEIR) model that accounts for misclassification error and selection bias, and derive an analytic expression for the basic reproduction number [Formula: see text] as a function of false negative rates of the diagnostic tests and selection probabilities for getting tested. Analyzing data from the first two waves of the pandemic in India, we show that correcting for misclassification and selection leads to more accurate prediction in a test sample. We provide estimates of undetected infections and deaths between April 1, 2020 and August 31, 2021. At the end of the first wave in India, the estimated under‐reporting factor for cases was at 11.1 (95% CI: 10.7,11.5) and for deaths at 3.58 (95% CI: 3.5,3.66) as of February 1, 2021, while they change to 19.2 (95% CI: 17.9, 19.9) and 4.55 (95% CI: 4.32, 4.68) as of July 1, 2021. Equivalently, 9.0% (95% CI: 8.7%, 9.3%) and 5.2% (95% CI: 5.0%, 5.6%) of total estimated infections were reported on these two dates, while 27.9% (95% CI: 27.3%, 28.6%) and 22% (95% CI: 21.4%, 23.1%) of estimated total deaths were reported. Extensive simulation studies demonstrate the effect of misclassification and selection on estimation of [Formula: see text] and prediction of future infections. A R‐package SEIRfansy is developed for broader dissemination. John Wiley and Sons Inc. 2022-02-27 2022-06-15 /pmc/articles/PMC9035093/ /pubmed/35224743 http://dx.doi.org/10.1002/sim.9357 Text en © 2022 The Authors. Statistics in Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Articles
Bhaduri, Ritwik
Kundu, Ritoban
Purkayastha, Soumik
Kleinsasser, Michael
Beesley, Lauren J.
Mukherjee, Bhramar
Datta, Jyotishka
Extending the susceptible‐exposed‐infected‐removed (SEIR) model to handle the false negative rate and symptom‐based administration of COVID‐19 diagnostic tests: SEIR‐fansy
title Extending the susceptible‐exposed‐infected‐removed (SEIR) model to handle the false negative rate and symptom‐based administration of COVID‐19 diagnostic tests: SEIR‐fansy
title_full Extending the susceptible‐exposed‐infected‐removed (SEIR) model to handle the false negative rate and symptom‐based administration of COVID‐19 diagnostic tests: SEIR‐fansy
title_fullStr Extending the susceptible‐exposed‐infected‐removed (SEIR) model to handle the false negative rate and symptom‐based administration of COVID‐19 diagnostic tests: SEIR‐fansy
title_full_unstemmed Extending the susceptible‐exposed‐infected‐removed (SEIR) model to handle the false negative rate and symptom‐based administration of COVID‐19 diagnostic tests: SEIR‐fansy
title_short Extending the susceptible‐exposed‐infected‐removed (SEIR) model to handle the false negative rate and symptom‐based administration of COVID‐19 diagnostic tests: SEIR‐fansy
title_sort extending the susceptible‐exposed‐infected‐removed (seir) model to handle the false negative rate and symptom‐based administration of covid‐19 diagnostic tests: seir‐fansy
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035093/
https://www.ncbi.nlm.nih.gov/pubmed/35224743
http://dx.doi.org/10.1002/sim.9357
work_keys_str_mv AT bhaduriritwik extendingthesusceptibleexposedinfectedremovedseirmodeltohandlethefalsenegativerateandsymptombasedadministrationofcovid19diagnostictestsseirfansy
AT kunduritoban extendingthesusceptibleexposedinfectedremovedseirmodeltohandlethefalsenegativerateandsymptombasedadministrationofcovid19diagnostictestsseirfansy
AT purkayasthasoumik extendingthesusceptibleexposedinfectedremovedseirmodeltohandlethefalsenegativerateandsymptombasedadministrationofcovid19diagnostictestsseirfansy
AT kleinsassermichael extendingthesusceptibleexposedinfectedremovedseirmodeltohandlethefalsenegativerateandsymptombasedadministrationofcovid19diagnostictestsseirfansy
AT beesleylaurenj extendingthesusceptibleexposedinfectedremovedseirmodeltohandlethefalsenegativerateandsymptombasedadministrationofcovid19diagnostictestsseirfansy
AT mukherjeebhramar extendingthesusceptibleexposedinfectedremovedseirmodeltohandlethefalsenegativerateandsymptombasedadministrationofcovid19diagnostictestsseirfansy
AT dattajyotishka extendingthesusceptibleexposedinfectedremovedseirmodeltohandlethefalsenegativerateandsymptombasedadministrationofcovid19diagnostictestsseirfansy